immediate-release tablet

DRUG2 trials

Sponsors

Cardurion Pharmaceuticals Inc.

Conditions

Heart failure (HF) with reduced ejection fraction (HFrEF)chronic heart failure

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction

CompletedCTIS2023-508736-62-00

Cardurion Pharmaceuticals Inc.Heart failure (HF) with reduced ejection fraction (HFrEF)

Start: 2024-08-08End: 2025-10-10Target: 265Updated: 2025-06-11

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction

CompletedCTIS2023-508737-13-00

Cardurion Pharmaceuticals Inc.chronic heart failure

Start: 2024-08-08End: 2025-08-29Target: 128Updated: 2025-06-12